Register
Login:
Share:
Email Facebook Twitter

EXCLUSIVE: Aura Energy #Aura to IPO Swedish Vanadium prospect Watch Here

EXCLUSIVE: Aura Energy #Aura to IPO Swedish Vanadium prospect


Vectura Share Price (VEC)



Share Price Information for Vectura (VEC)


Share Price: 81.80Bid: 81.75Ask: 82.00Change: 0.15 (+0.18%)Riser - Vectura
Spread: 0.25Spread as %: 0.31%Open: 81.00High: 81.80Low: 80.55Yesterday’s Close: 81.65

Vectura Group Plc Ord 0.025P

Vectura is listed in the FTSE All-Share, FTSE Small Cap
Vectura is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
81.80
Share Price SpacerBid
81.75
Share Price SpacerAsk
82.00
Share Price SpacerChange
0.18%0.15
Share Price SpacerVolume
440,165
Share Price SpacerOpen
81.00
Share Price SpacerHigh
81.80
Share Price SpacerLow
80.55
Share Price SpacerClose
81.65
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 665.22m £544.15m 7,500

52 Week High 127.20 52 Week High Date 28-DEC-2017
52 Week Low 68.00 52 Week Low Date 21-MAR-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
196 350,992 108,419 -6.492 -12.60 0.00 0.00


London South East Users info for Vectura




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

19-Jun-18
13:11:52
81.80
210
Buy* 
81.55
81.80
171.78
Trade Type:
Automatic execution

19-Jun-18
13:11:15
81.65
47,790
Sell* 
81.55
81.80
39.02k
Trade Type:
Ordinary

19-Jun-18
13:11:08
81.65
48,000
Sell* 
81.55
81.80
39.19k
Trade Type:
Ordinary




View more Vectura trades >>

Directors Deals for Vectura (VEC)
Trade DateActionNotifierPriceCurrencyAmountHolding
08-Nov-17Buy
Trade Notifier Information for Vectura Group
Andrew Derodra held the position of CFO at Vectura Group at the time of this trade.
 Andrew Derodra
96.35GBX156415740
06-Oct-17Buy
Trade Notifier Information for Vectura Group
Andrew Derodra held the position of CFO at Vectura Group at the time of this trade.
 Andrew Derodra
105.9GBX142415584
12-Sep-17Buy
Trade Notifier Information for Vectura Group
Bruno Angelici held the position of Non-Executive Chairman at Vectura Group at the time of this trade.
 Bruno Angelici
98.66GBX70,000162903
View more Vectura directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Thu 17:32MrBBRE: Mylan refused again!84.00No Opinion
Should have been viewed as good news for us & HIK but the Market clearly considers that Mylans second failure is an indication that we will fail at the second hurdle too, delaying the fateful day further.An optimist would suggest that we wont make that mistake second time around & we may then have some earlier mover advantage in the generic Advair stakes.The Market is struggling to see any positives in poor old Vec , endorsing my view in my previous posting.
Thu 08:56LindonMylan refused again!84.00No Opinion
(Reuters) - Mylan NV said on Wednesday that U.S. health regulators were unable to approve its generic version of GlaxoSmithKline’s blockbuster inhaled lung drug Advair for the second time, as they found “minor deficiencies” in the treatment.

Shares of Mylan fell 4.5 percent to $39.80 after the bell.

Mylan did not provide details on the nature of the deficiencies cited by the U.S. Food And Drug Administration and it remains unclear whether the company will be able to… Read More
9 Jun '18MrBBRE: Advair83.80No Opinion
Hardly a surprise that FDA May try to protect GSK & fact that their head honcho is ex GSK is possibly relevant .I found myself with a large holding here following the acquisition of my SKP shares & Vec has been an exceptionally disappointing investment ,so far .However ,they have some great products & patents ,£100 mill in the bank & I am beginning to wonder whether the worm may be about to turn .We all know that we investors should press our positions in winners & cut… Read More
7 Jun '18MulderShorts down a lot83.30Buy
but SP flat/down. Bizarre.
21 May '18LindonRE: Time will tell85.25No Opinion
Around eighteen.... months! Minimum!
21 May '18LindonTime will tell85.25Strong Buy
Shorters, usually hedge funds, are as their name suggests... short term investors! IMO the problem VEC has is that 'near term events' could go either way. In the absence of any other news in the interim, the next 'event' will be the FDA decision for Mylan's hopes of an Advair generic approval, the FDA decision is due next month. The fact that it's perceived by most that there isn't any premium in the current VEC sp price for Adviar probably won't stop market sentiment moving the sp back to… Read More

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Vectura (VEC) >>

Please login or register to post a message on Share Chat.





Vectura Group Plc Ord 0.025P home pageWebsite: Vectura Group Plc Ord 0.025P
Website Description: Vectura



Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.